Search
18/08/2022
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group
del Alcazar, E, Lopez-Ferrer, A, Martinez-Domenech, A, Julia, M, Ruiz-Villaverde, R, Fernandez-Freire, LR, Notario, J, Llamas-Velasco, M, Ferran, M, Carrascosa, JM. Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(6)DOI:10.1080/09546634.2022.2079596. PMID:35593480. IF:2.900(Q2/4D).
18/08/2022
Definition of clinically insignificant residual fragments after percutaneous nephrolithotomy among urologists: a world-wide survey by EAU-YAU Endourology and Urolithiasis Working Group
Tonyali, S, Emiliani, E, Sener, TE, Pietropaolo, A, Ozsoy, M, Aboumarzouk, O, Somani, B, Kallidonis, P, Coninck, VMJD, Talso, M, Keller, EX, Macchione, N, Tailly, T. Definition of clinically insignificant residual fragments after percutaneous nephrolithotomy among urologists: a world-wide survey by EAU-YAU Endourology and Urolithiasis Working Group. Central European Journal Of Urology. 2022; 75(3)DOI:10.5173/ceju.2022.0115. PMID:36381161. IF:(Q/D).
18/08/2022
Consequences of Cushing's Syndrome: Health Versus Personal Costs
Webb, SM, Valassi, E. Consequences of Cushing's Syndrome: Health Versus Personal Costs. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(9)DOI:10.1210/clinem/dgac269. PMID:35511590. IF:5.800(Q1/3D).
16/08/2022
The Location of Disease-Causing DES Variants Determines the Severity of Phenotype and the Morphology of Sarcoplasmic Aggregates
Silva, AMS, Rodrigo, P, Moreno, CAM, Mendonca, RD, Estephan, ED, Camelo, CG, Campos, ED, Dias, AT, Nascimento, AM, Kulikowski, LD, Oliveira, ASB, Reed, UC, Goldfarb, LG, Olive, M, Zanoteli, E. The Location of Disease-Causing DES Variants Determines the Severity of Phenotype and the Morphology of Sarcoplasmic Aggregates. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2022; 81(9)DOI:10.1093/jnen/nlac063. PMID:35898174. IF:3.200(Q2/5D).